Floatz logo

Dtpw-Hbv/Hib-Menac Conjugate Vaccine

Hepatitis B Virus Infection

GlaxoSmithKlinevaccinePhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
89/ 100

Competitive context

23 Active assets in the Hepatitis B Virus Infection cohort.

Asset / SponsorPhaseRating
Entecavir
Sun Yat-sen University
Phase 4BBB
Lamivudine
Fudan University
Phase 4BBB
tenofovir
Ruijin Hospital
Phase 4BB
TENOFOVIR BIS(ISOPROPYLOXYCARBONYLOXYMETHYL) ESTER
West China Hospital
Phase 4BB
Hepatitis B Virus Vaccine
Eunice Dube
Phase 4BB

View all 43 →

Same molecule, other indications

Dtpw-Hbv/Hib-Menac Conjugate Vaccine is also rated in:

haemophilus infectious diseaseDormant
B
Indicative ·
57 / 100
View asset →
tetanusDormant
B
Indicative ·
57 / 100
View asset →
pertussisDormant
B
Indicative ·
57 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →